6:11 PM
 | 
Aug 06, 2008
 |  BC Extra  |  Financial News

Exelixis falls after downgrade

Exelixis (NASDAQ:EXEL) fell $1.14 (16%) to $5.97 on Wednesday after an analyst downgraded the stock. Canaccord's Joseph Pantginis downgraded from "buy" to "hold," citing the stock's run up of 50% in the past four weeks and a lack of major catalysts for the company in...

Read the full 210 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >